Xinhua Pharmaceutical

SZSE · 000756

shenzhen stock exchangereal estate infrastructure
Market Cap$8.9B
Revenue$8.7B
P/E Ratio33.0
Employees7240
Listed OnSZSE
Ticker000756
IndustryDrug Manufacturers - Specialty & Generic
CEO / ExecMr. Tongqing He
HeadquartersZibo
MarketMainland China
Websitewww.xhzy.com

Overview

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People's Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also

Data Note

This record combines exchange-directory fields with selected profile enrichment. Treat market data, leadership and financial figures as directional unless verified against company filings, exchange announcements or the issuer's own disclosures.